Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,928 | 376 | 83.3% |
| Consulting Fee | $1,642 | 4 | 15.3% |
| Education | $150.49 | 7 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Hologic, LLC | $1,603 | 6 | $0 (2022) |
| ABBVIE INC. | $1,227 | 63 | $0 (2024) |
| Avanos Medical | $1,044 | 16 | $0 (2024) |
| Amgen Inc. | $675.41 | 10 | $0 (2024) |
| Daiichi Sankyo Inc. | $671.48 | 26 | $0 (2022) |
| MAYNE PHARMA INC. | $463.73 | 2 | $0 (2022) |
| Lupin Inc. | $456.82 | 27 | $0 (2021) |
| PFIZER INC. | $392.80 | 22 | $0 (2024) |
| Astellas Pharma US Inc | $359.97 | 18 | $0 (2024) |
| Exeltis, USA Inc. | $356.76 | 20 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,339 | 49 | Amgen Inc. ($277.95) |
| 2023 | $1,138 | 50 | Astellas Pharma US Inc ($288.59) |
| 2022 | $2,689 | 57 | Hologic, LLC ($1,500) |
| 2021 | $1,959 | 72 | MAYNE PHARMA INC. ($448.66) |
| 2020 | $660.89 | 33 | Lupin Inc. ($169.00) |
| 2019 | $1,510 | 50 | Avanos Medical ($430.28) |
| 2018 | $831.71 | 42 | Duchesnay USA Incorporated ($155.13) |
| 2017 | $593.08 | 34 | Amgen Inc. ($104.27) |
All Payment Transactions
387 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | PFIZER INC. | ABRYSVO (Biological) | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: VACCINES | ||||||
| 12/15/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $138.90 | General |
| Category: Bone Health | ||||||
| 12/09/2024 | Bayer Healthcare Pharmaceuticals Inc. | Stivarga (Drug), Vitrakvi, Nubeqa | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: Oncology | ||||||
| 12/05/2024 | Avanos Medical | ON-Q* PUMP AND ACCESSORIES (Device) | Food and Beverage | In-kind items and services | $42.48 | General |
| Category: SURGICAL PAIN | ||||||
| 11/14/2024 | PFIZER INC. | ABRYSVO (Biological) | Food and Beverage | In-kind items and services | $84.61 | General |
| Category: VACCINES | ||||||
| 11/12/2024 | ABBVIE INC. | LILETTA (Drug) | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: WOMENS HEALTH | ||||||
| 10/29/2024 | Sage Therapeutics, Inc. | ZURZUVAE (Drug) | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: PSYCHIATRY/PSYCHOLOGY | ||||||
| 10/15/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: Biological | ||||||
| 10/15/2024 | PFIZER INC. | PREMARIN (Drug), DUAVEE, MYFEMBREE | Food and Beverage | In-kind items and services | $1.23 | General |
| Category: WOMENS HEALTH | ||||||
| 10/01/2024 | MAYNE PHARMA COMMERCIAL LLC | ANNOVERA (Drug) | Food and Beverage | In-kind items and services | $119.50 | General |
| Category: CONTRACEPTIVE | ||||||
| 10/01/2024 | PFIZER INC. | ABRYSVO (Biological) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: VACCINES | ||||||
| 09/12/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: Biological | ||||||
| 09/10/2024 | PFIZER INC. | PREMARIN (Drug), ESTRING, DUAVEE | Food and Beverage | In-kind items and services | $8.88 | General |
| Category: WOMENS HEALTH | ||||||
| 09/05/2024 | Organon Llc | — | Food and Beverage | In-kind items and services | $90.56 | General |
| 09/04/2024 | Organon Llc | JADA SYSTEM (Device) | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: POSTPARTUM UTERINE HEMORRHAGING | ||||||
| 08/26/2024 | PFIZER INC. | PREMARIN (Drug), ESTRING, DUAVEE | Food and Beverage | In-kind items and services | $1.86 | General |
| Category: WOMENS HEALTH | ||||||
| 08/15/2024 | Organon Llc | JADA SYSTEM (Device) | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: POSTPARTUM UTERINE HEMORRHAGING | ||||||
| 08/06/2024 | ABBVIE INC. | LILETTA (Drug) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: WOMENS HEALTH | ||||||
| 07/30/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $51.11 | General |
| Category: Hematology | ||||||
| 07/19/2024 | Avanos Medical | ON-Q* PUMP AND ACCESSORIES (Device) | Food and Beverage | In-kind items and services | $40.23 | General |
| Category: SURGICAL PAIN | ||||||
| 07/17/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $52.40 | General |
| Category: Hematology | ||||||
| 07/17/2024 | PFIZER INC. | PREMARIN (Drug), DUAVEE, MYFEMBREE | Food and Beverage | In-kind items and services | $3.03 | General |
| Category: WOMENS HEALTH | ||||||
| 06/12/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: CONTRACEPTIVE | ||||||
| 06/06/2024 | Organon Llc | JADA SYSTEM (Device) | Food and Beverage | In-kind items and services | $6.31 | General |
| Category: POSTPARTUM UTERINE HEMORRHAGING | ||||||
| 06/04/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $47.64 | General |
| Category: Hematology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 149 | 155 | $23,562 | $7,802 |
| 2022 | 5 | 109 | 114 | $19,510 | $6,344 |
| 2021 | 5 | 113 | 116 | $18,484 | $6,392 |
| 2020 | 6 | 203 | 209 | $29,880 | $10,314 |
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 77067 | Screening mammography | Office | 2023 | 43 | 43 | $12,900 | $3,614 | 28.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 18 | 23 | $4,600 | $1,673 | 36.4% |
| 77063 | Screening 3d breast mammography | Office | 2023 | 41 | 41 | $2,911 | $940.13 | 32.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 14 | 15 | $2,025 | $673.56 | 33.3% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 16 | 16 | $616.00 | $600.96 | 97.6% |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 2023 | 17 | 17 | $510.00 | $300.73 | 59.0% |
| 77067 | Screening mammography | Office | 2022 | 35 | 35 | $10,500 | $2,924 | 27.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 19 | 24 | $4,800 | $1,499 | 31.2% |
| 77063 | Screening 3d breast mammography | Office | 2022 | 32 | 32 | $2,272 | $742.41 | 32.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 11 | 11 | $1,485 | $727.57 | 49.0% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 12 | 12 | $452.95 | $450.85 | 99.5% |
| 77067 | Screening mammography of both breasts | Office | 2021 | 31 | 31 | $9,300 | $2,679 | 28.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 25 | 28 | $5,600 | $2,380 | 42.5% |
| 77063 | Screening digital tomography of both breasts | Office | 2021 | 30 | 30 | $2,174 | $727.77 | 33.5% |
| 77080 | Bone density measurement of the core or central skeleton (e.g., hips, pelvis, spine) | Office | 2021 | 12 | 12 | $960.00 | $334.92 | 34.9% |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 2021 | 15 | 15 | $450.00 | $270.75 | 60.2% |
| 77067 | Mammography of both breasts | Office | 2020 | 37 | 37 | $11,100 | $3,529 | 31.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 39 | 43 | $8,600 | $3,120 | 36.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 31 | 33 | $4,455 | $1,438 | 32.3% |
| 77063 | Screening digital tomography of both breasts | Office | 2020 | 38 | 38 | $2,850 | $916.49 | 32.2% |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 2020 | 43 | 43 | $1,290 | $772.91 | 59.9% |
| 77080 | Bone density measurement using dedicated x-ray machine | Office | 2020 | 15 | 15 | $1,585 | $537.89 | 33.9% |
About Dr. Paul Lin, MD
Dr. Paul Lin, MD is a Obstetrics & Gynecology healthcare provider based in Longview, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1497722714.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Paul Lin, MD has received a total of $10,720 in payments from pharmaceutical and medical device companies, with $1,339 received in 2024. These payments were reported across 387 transactions from 51 companies. The most common payment nature is "Food and Beverage" ($8,928).
As a Medicare-enrolled provider, Lin has provided services to 574 Medicare beneficiaries, totaling 594 services with total Medicare billing of $30,852. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Practice Information
- Specialty Obstetrics & Gynecology
- Location Longview, TX
- Active Since 03/06/2006
- Last Updated 01/15/2025
- Taxonomy Code 207V00000X
- Entity Type Individual
- NPI Number 1497722714
Products in Payments
- NOVASURE (Device) $1,565
- ON-Q* PUMP AND ACCESSORIES (Device) $1,044
- INJECTAFER (Drug) $671.48
- EVENITY (Biological) $433.43
- LO LOESTRIN FE (Drug) $384.93
- SOLOSEC (Drug) $361.05
- Osphena (Drug) $346.42
- ORILISSA (Drug) $346.13
- SLYND (Drug) $344.79
- Orilissa (Drug) $268.96
- Veozah (Drug) $257.68
- ACCRUFER (Drug) $248.81
- Prolia (Biological) $228.83
- Phexxi (Drug) $227.07
- Kyleena (Drug) $212.36
- PREMARIN (Drug) $206.70
- Balcoltra (Drug) $201.78
- ANNOVERA (Drug) $196.02
- LILETTA (Drug) $167.80
- ABRYSVO (Biological) $136.51
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in Longview
Clarissa Weiss, M.d, M.D
Obstetrics & Gynecology — Payments: $12,538
Laura Lefever, Do, DO
Obstetrics & Gynecology — Payments: $9,628
Dr. Henry Gor, Md, MD
Obstetrics & Gynecology — Payments: $7,099
Dr. Robert Cruz, M.d, M.D
Obstetrics & Gynecology — Payments: $7,041
Dr. James Dozier, Md, MD
Obstetrics & Gynecology — Payments: $7,035
Dr. Graham Weaver, Md, MD
Obstetrics & Gynecology — Payments: $5,898